ReadyRx GLP-1
ReadyRx GLP-1 is a telehealth program that connects adults with licensed U.S. providers who may prescribe compounded semaglutide or compounded tirzepatide for weight management, following an online medical evaluation, with medication shipped directly to qualifying patients.
Quick Highlights
- 100% online medical intake and consultation
- Compounded semaglutide or tirzepatide
- Auto-renewing subscription, not a one-time purchase
- Free 1–2 day shipping, per the official site
- Licensed U.S. compounding pharmacies, per the official site
Product Details
| Detail | Information |
| Brand | ReadyRx |
| Product type | Telehealth weight-management prescription program |
| Medications offered | Compounded semaglutide; compounded tirzepatide. A provider may instead prescribe an FDA-approved branded medication (e.g., Zepbound®, or off-label Ozempic®), fulfilled by a separate licensed partner pharmacy |
| Delivery format | Injectable, self-administered per provider instructions |
| Consultation model | Online intake reviewed by a licensed, board-certified clinician, who has sole discretion to prescribe or decline |
| Purchase model | Auto-renewing subscription; billed at intervals disclosed at checkout until cancelled |
| Listed starting price | $149/month as advertised on the official landing page; a third-party pharmacy listing separately shows $179 for semaglutide and $255 for tirzepatide |
| Shipping | Free, described as 1–2 day delivery on the official site |
| Insurance | Not required; cash-pay model |
| HSA/FSA eligibility | Stated as eligible on the official site |
| Compounding pharmacy | Described as FDA-registered, U.S.-based compounding pharmacies, according to the official site; specific pharmacy names not publicly disclosed on the pages reviewed |
| Third-party accreditation shown | LegitScript-approved seal displayed on the official site |
| Availability | Online only, through the official ReadyRx intake form |
What Is ReadyRx GLP-1?
ReadyRx GLP-1 is a telehealth service, not a retail product a consumer simply buys off a shelf. Patients complete an online health intake, and a licensed provider decides – at their sole discretion – whether a GLP-1 prescription is medically appropriate. If approved, medication is typically a compounded version of semaglutide or tirzepatide, prepared by an independent, state-licensed compounding pharmacy.
According to the official site, a provider may instead determine that an FDA-approved branded medication, such as Zepbound® (approved for chronic weight management) or Ozempic® (approved for type 2 diabetes, sometimes prescribed off-label for weight management), is more appropriate; in that case the prescription is filled through a separate licensed partner pharmacy.
Who May Consider ReadyRx GLP-1?
Adults who want physician-guided support for weight management, and who prefer an online intake process over an in-person clinic visit, may consider applying. The official site frames this toward people who have hit a plateau with diet and exercise alone, positioning medical treatment as an additional tool rather than a replacement for lifestyle changes.
Eligibility is not guaranteed. A licensed provider reviews medical history, current medications and health risks before deciding whether to prescribe, and the program is not appropriate for everyone – see Safety Information below for conditions that would exclude someone from treatment.
How Are These Medications Intended to Work?
Semaglutide and tirzepatide belong to the GLP-1 receptor agonist drug class (tirzepatide is also a GIP receptor agonist). According to the manufacturer, these medications are intended to reduce appetite, increase feelings of fullness, and slow digestion, which may support portion control and reduced overeating as part of a medically supervised weight-management plan. Tirzepatide is described by ReadyRx as the same active ingredient used in the branded medications Mounjaro and Zepbound.
Active Ingredients
Compounded Semaglutide
Semaglutide is a GLP-1 receptor agonist. As a compound medication, this version is prepared by a licensed compounding pharmacy rather than manufactured as an FDA-approved branded product, and it has not been reviewed by the FDA for safety, effectiveness or quality. Exact dose and titration schedule are determined by the prescribing provider and are not disclosed on the pages reviewed.
Compounded Tirzepatide
Tirzepatide is a dual GLP-1/GIP receptor agonist, the same active ingredient used in the FDA-approved branded medications Mounjaro and Zepbound. As with compounded semaglutide, this compounded version is prepared by a licensed pharmacy rather than being an FDA-approved product itself. Dose and titration are set by the prescribing provider.
How the Program Works
- Complete a short online health intake form.
- A licensed, board-certified clinician reviews your medical history and determines eligibility, at their sole discretion.
- If approved, a prescription is issued for a compounded or branded GLP-1 medication, as clinically appropriate.
- Medication and injection supplies ship from a licensed pharmacy, described as arriving in 1–2 days with free shipping.
- Ongoing check-ins and provider support continue through the subscription, per the official program description.
This program requires a valid prescription; it is not an over-the-counter product, and there is no fixed “how to use” dosing schedule to publish here – dosing is individualized by the prescribing provider.
Safety Information – Boxed Warning and Precautions
This is prescription medical information, not general wellness content, and none of it should be skipped.
Boxed warning (the FDA’s most serious warning level): GLP-1 medications in this class carry a boxed warning for the possible risk of thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), based on findings in animal studies.
Do not use, and this program is not appropriate, if:
- You or a family member has a personal or family history of MTC.
- You have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- You are pregnant or planning to become pregnant.
Seek immediate medical attention if you experience:
- A lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath (possible thyroid-related symptoms).
- Severe abdominal pain (possible sign of pancreatitis).
Eligibility and Prescribing Limitations
- Compounded medications are only available where a provider determines an individualized clinical need exists, and availability varies by state.
Pros
- Requires licensed physician evaluation before any prescription is issued
- Offers both compounded and, where appropriate, FDA-approved branded medication pathways
- No insurance required; transparent cash-pay pricing, per the official site
- Free 1–2 day shipping described on the official site
- Displays a LegitScript-approved compliance seal
Cons
- This drug class carries a boxed warning for possible thyroid C-cell tumors
- Structured as an auto-renewing subscription rather than a one-time purchase
Pricing and Refund Policy
Pricing shown differs across three sources reviewed: the official landing page, a screenshot of the plan-selection step inside the ReadyRx checkout flow, and a third-party pharmacy listing. All three are reported below rather than reconciled into a single figure.
- Official ReadyRx landing page: Starting at $149/month, with up to a $100 instant discount for new customers.
- ReadyRx plan-selection screen: From $199/month, with an additional $20 off the first order. Marked as “Most Popular.”
- Third-party pharmacy listing (Riccio Family Pharmacy): $179/month.
- Billing: Auto-renewing subscription, charged at disclosed intervals until cancelled.
The gap between the $149 landing-page figure and the 199/275 checkout-screen figures suggests $149 may be a lowest-possible promotional starting price (e.g., after maximum discount or for a specific dose/tier) rather than the standard first-tier price shown once a medication is selected. This wasn’t independently confirmed, since the full checkout flow wasn’t fetched.
The official site states pricing is available to new customers only, is subject to change, has no cash value, and cannot be combined with other offers. It also states a 100% refund if a patient is found not clinically eligible after evaluation. The third-party listing separately describes a 28-week money-back guarantee for qualifying patients, with strict conditions around treatment adherence, progress logs, dose requirements and weight verification – these specific conditions were not independently confirmed on the official ReadyRx page.
Pricing and availability were checked on August 22, 2026, and may change on the official website.
Pharmacist/Clinical Note
GLP-1 medications require ongoing medical supervision, not a one-time purchase decision. Before starting, patients should disclose their complete medical history – including any personal or family history of thyroid cancer or MEN 2 – and every current medication, since GLP-1 drugs can interact with other treatments, including insulin and other diabetes medications. Anyone with questions about compounded versus branded formulations should raise them directly with their prescribing provider.
Frequently Asked Questions
Is ReadyRx GLP-1 a prescription program?
Yes. It requires an online medical evaluation by a licensed provider, who decides whether to prescribe based on your health history, at their sole discretion.
What medications does ReadyRx use?
Primarily compounded semaglutide or compounded tirzepatide; a provider may instead prescribe an FDA-approved branded medication like Zepbound® through a partner pharmacy.
Is this the same as taking Ozempic or Zepbound?
Compounded medications share the same active ingredient class but are not FDA-approved and have not been shown equivalent to the branded products; only a provider-prescribed
Is this a one-time purchase?
No. It is billed as an auto-renewing subscription at intervals disclosed at checkout, and can be cancelled per the program’s Terms of Use.
Does insurance cover this?
No insurance is required or apparently accepted; it operates on a cash-pay model, according to the official site.
Sources and Content Review Information
- Official landing page: https://readyrx.com/lp/wl4ef
- Official Terms of Use, Cookie and Communication policies: linked from the official landing page
- Date information was checked: August 22, 2026
Customer Reviews
There are no approved reviews yet. Be the first to add a review.

Add a Review